ANXA9 and breast carcinoma: As expected, a positive correlation between the expression levels of ANXA9 and BCL2 was observed in breast cancer patients (n = 1104, Supplementary Figure S5A), as well as a negative correlation between miR-186-5p and BCL2 (n = 1085, Supplementary Figure S5B).